BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 18158160)

  • 21. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
    Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
    Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
    J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chaperonin-mediated de novo generation of prion protein aggregates.
    Stöckel J; Hartl FU
    J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of Syrian hamster prion protein rPrP(90-231).
    Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
    Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
    Ollesch J; Künnemann E; Glockshuber R; Gerwert K
    Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity between the C-terminal domain of the prion protein and chimpanzee cytomegalovirus glycoprotein UL9.
    Kuznetsov IB; Rackovsky S
    Protein Eng; 2003 Dec; 16(12):861-3. PubMed ID: 14983063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow conformational dynamics in the hamster prion protein.
    Kuwata K; Kamatari YO; Akasaka K; James TL
    Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
    Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
    Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
    Safar J; Roller PP; Gajdusek DC; Gibbs CJ
    Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
    Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein.
    Steinert PM; Candi E; Tarcsa E; Marekov LN; Sette M; Paci M; Ciani B; Guerrieri P; Melino G
    Cell Death Differ; 1999 Sep; 6(9):916-30. PubMed ID: 10510474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.